Clinical trial
How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement…
NCT00040196 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00040196 |
|---|---|
| Title | How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance |
| Official title | Dopaminergic Modulation of Cerebral Connectivity During Sequential Finger Movements |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Parkinson Disease |
| Enrollment | 133 |
| Start date | Jun 19, 2002 |
| Primary completion | Jul 9, 2009 |
| Completion | Jul 9, 2009 |
| First posted | Jun 24, 2002 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: